Clinical Trials Directory

Trials / Terminated

TerminatedNCT02345096

Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis

A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Lesaffre International · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the effect of a specific strain of Saccharomyces cerevisiae on improving the effectiveness of conventional treatment of vulvo-vaginal candidiasis. This is a randomized, double-blind, placebo-controlled study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSaccharomyces cerevisiae
DIETARY_SUPPLEMENTPlacebo

Timeline

Start date
2015-01-01
Primary completion
2015-06-01
Completion
2016-08-01
First posted
2015-01-26
Last updated
2016-12-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02345096. Inclusion in this directory is not an endorsement.

Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis (NCT02345096) · Clinical Trials Directory